Target intelligence / Profile preview

Colonic mucosa and lumen

Molecular classification
Other (Anatomical compartment), Tissue layer
01

Overview

The colonic mucosa and lumen represent the internal anatomical environment of the large intestine, consisting of the epithelial lining and the central cavity where fecal matter is processed. The mucosa serves as a critical semi-permeable barrier that facilitates the absorption of water and electrolytes while preventing the translocation of pathogens into the systemic circulation (StatPearls, 2023). The lumen houses a complex ecosystem of microbiota that plays a vital role in metabolic health, vitamin synthesis, and immune modulation (Nature Reviews Gastroenterology & Hepatology, 2020). In pharmacological contexts, this region is the primary site of action for locally delivered therapies, such as aminosalicylates and corticosteroids, which treat inflammatory bowel diseases by making direct contact with the diseased tissue (Mayo Clinic, 2024). Because it is a multi-cellular tissue compartment rather than a single protein, enzyme, or receptor, it is classified as an anatomical site of drug action rather than a specific molecular target. Therapeutic strategies often focus on maintaining mucosal integrity or modulating the chemical and microbial environment within the lumen to manage gastrointestinal disorders (NIH, 2023).

Other names
Large intestinal mucosaColonic liningIntestinal lumenColonic epithelium
02

Mechanism of action

Drugs targeting this region typically exert their effects through local topical contact with the epithelial surface to reduce inflammation, or by modulating the luminal environment through antimicrobial activity or osmotic changes to alter stool consistency and microbial composition.

03

Biological functions

Water and electrolyte absorptionMucus secretionPhysical and immunological barrier functionMicrobiome habitatImmune surveillance
04

Disease associations

InflammationCancerInfectionUlcerative colitisCrohn's diseaseIrritable bowel syndrome
05

Safety considerations

Systemic absorption of locally intended agentsDisruption of commensal gut microbiota (dysbiosis)Risk of mucosal perforationDevelopment of intestinal strictures
06

Interacting drugs

Mesalamine

6 more in the full profile.

07

Biomarkers

Fecal calprotectinFecal immunochemical test (FIT)C-reactive protein (CRP)Endoscopic mucosal healing score

Beyond the preview

Go deeper on Colonic mucosa and lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic mucosa and lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call